Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Loperamide × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10 Gastrointestinal 5 Sarcoma 3 Gynecologic 3 Thoracic 2 Tumor-Agnostic 1 Dermatologic 1 CNS 1

Conditions

Interventions

pembrolizumab 85 Paclitaxel 75 Carboplatin 69 Gemcitabine 67 Nivolumab 50 Cisplatin 49 Docetaxel 47 Bevacizumab 46 Fluorouracil 39 Capecitabine 39 Magnetic Resonance Spectroscopy 37 Radiotherapy 34 Irinotecan 32 Oxaliplatin 31 Erlotinib Hydrochloride 31 Biopsy 31 Pemetrexed 30 Standard of Care 28 atezolizumab 26 Trastuzumab 26 Leucovorin 26 Specimen Handling 25 Sorafenib 24 Radiosurgery 24 Everolimus 24 Cyclophosphamide 24 Cetuximab 24 Blood Specimen Collection 24 Ipilimumab 22 Surveys and Questionnaires 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02323516 2015-12-08

ASPIDIA

Centre Francois Baclesse

Phase 2 Withdrawn

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡